Filing Details

Accession Number:
0000891293-22-000033
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-17 16:57:44
Reporting Period:
2022-06-17
Accepted Time:
2022-06-17 16:57:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891293 Cti Biopharma Corp CTIC Pharmaceutical Preparations (2834) 911533912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1276750 David Kirske Cti Biopharma Corp.
3101 Western Ave., Suite 800
Seattle WA 98121
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-17 10,000 $1.00 17,397 No 4 M Direct
Common Stock Disposition 2022-06-17 10,000 $6.00 7,397 No 4 S Direct
Common Stock Acquisiton 2022-06-17 50,000 $3.30 57,397 No 4 M Direct
Common Stock Disposition 2022-06-17 50,000 $6.25 7,397 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2022-06-17 10,000 $0.00 10,000 $1.00
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2022-06-17 50,000 $0.00 50,000 $3.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
340,000 2030-03-11 No 4 M Direct
150,000 2031-03-10 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a 10b5-1 sales plan adopted by the reporting person.
  2. One sixth of the shares underlying the option vested on 9/11/2020 and semi-annually thereafter until all the underlying shares will be fully vested on 3/11/2023.
  3. One sixth of the shares underlying the option vested on 9/10/2021 and semi-annually thereafter until all the underlying shares will be fully vested on 3/10/2024.